Symbols / UNH $317.24 +1.01% UnitedHealth Group Incorporated
UNH Chart
About
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Healthcare Plans | Market Cap | 287.95B |
| Enterprise Value | 347.53B | Income | 12.06B | Sales | 447.57B |
| Book/sh | 103.87 | Cash/sh | 30.98 | Dividend Yield | 2.81% |
| Payout | 65.99% | Employees | 390000 | IPO | — |
| P/E | 24.00 | Forward P/E | 15.76 | PEG | — |
| P/S | 0.64 | P/B | 3.05 | P/C | — |
| EV/EBITDA | 16.07 | EV/Sales | 0.78 | Quick Ratio | 0.70 |
| Current Ratio | 0.79 | Debt/Eq | 81.62 | LT Debt/Eq | — |
| EPS (ttm) | 13.22 | EPS next Y | 20.13 | EPS Growth | -99.90% |
| Revenue Growth | 12.30% | Earnings | 2026-04-21 | ROA | 3.90% |
| ROE | 12.54% | ROIC | — | Gross Margin | 18.53% |
| Oper. Margin | 0.34% | Profit Margin | 2.69% | Shs Outstand | 907.68M |
| Shs Float | 899.99M | Short Float | 1.95% | Short Ratio | 2.04 |
| Short Interest | — | 52W High | 489.79 | 52W Low | 234.60 |
| Beta | 0.41 | Avg Volume | 10.08M | Volume | 2.57M |
| Target Price | $360.96 | Recom | Buy | Prev Close | $314.05 |
| Price | $317.24 | Change | 1.01% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-07 | main | Bernstein | Outperform → Outperform | $411 |
| 2026-04-01 | up | Raymond James | Market Perform → Outperform | $330 |
| 2026-02-05 | main | Mizuho | Outperform → Outperform | $350 |
| 2026-02-02 | main | Truist Securities | Buy → Buy | $370 |
| 2026-02-02 | main | JP Morgan | Overweight → Overweight | $389 |
| 2026-01-30 | main | Barclays | Overweight → Overweight | $327 |
| 2026-01-30 | main | Wells Fargo | Overweight → Overweight | $370 |
| 2026-01-28 | main | Jefferies | Buy → Buy | $340 |
| 2026-01-28 | main | Leerink Partners | Outperform → Outperform | $345 |
| 2026-01-28 | main | RBC Capital | Outperform → Outperform | $361 |
| 2026-01-28 | main | Oppenheimer | Outperform → Outperform | $385 |
| 2026-01-28 | main | UBS | Buy → Buy | $410 |
| 2026-01-23 | main | Morgan Stanley | Overweight → Overweight | $409 |
| 2026-01-05 | main | Barclays | Overweight → Overweight | $391 |
| 2025-10-30 | main | TD Cowen | Hold → Hold | $338 |
| 2025-10-30 | main | Bernstein | Outperform → Outperform | $440 |
| 2025-10-29 | main | UBS | Buy → Buy | $430 |
| 2025-10-29 | main | RBC Capital | Outperform → Outperform | $408 |
| 2025-10-29 | main | Piper Sandler | Overweight → Overweight | $417 |
| 2025-10-17 | main | Jefferies | Buy → Buy | $409 |
News
RSS: Latest UNH news- Is It Time To Reassess UnitedHealth Group (UNH) After This Year’s Sharp Share Price Slide - Yahoo Finance hu, 16 Apr 2026 21
- Fund targets utility shutoffs, bed bugs to keep D.C. seniors housed - Stock Titan hu, 16 Apr 2026 12
- Morgan Stanley Names UnitedHealth Stock (UNH) a Top Pick ahead of Q1 Earnings – Here’s Why - TipRanks hu, 16 Apr 2026 22
- UnitedHealth: Trust Is Broken - But The Model Isn't - Seeking Alpha Sun, 12 Apr 2026 13
- UnitedHealth Q1 Earnings Preview: Can it Dodge MA Pressure for a Beat? - Zacks Investment Research hu, 16 Apr 2026 16
- UnitedHealth Stock After a 20% YTD Drop: Here’s What’s Driving the Valuation - TIKR.com Fri, 27 Mar 2026 07
- UnitedHealth Doula Rollout And Investor Shifts Reshape UNH Valuation Story - simplywall.st Mon, 13 Apr 2026 23
- Falling Stock Price, Rising Dividend: UnitedHealth Fits the Dogs of the Dow Profile - 24/7 Wall St. Wed, 15 Apr 2026 11
- UnitedHealth Group Stock (UNH) Opinions on Senator's Recent Purchase - Quiver Quantitative hu, 19 Mar 2026 07
- Is UnitedHealth Group (UNH) The Best Healthcare Stock to Buy According to Billionaire Ken Griffin? - Yahoo Finance Sat, 04 Apr 2026 07
- Is UnitedHealth Stock (UNH) a Buy Ahead of Q1 Earnings? Here’s What Wall Street Thinks - TipRanks Mon, 06 Apr 2026 07
- UnitedHealth: Solid Annual Total Return Potential Makes It A Buy (NYSE:UNH) - Seeking Alpha ue, 14 Apr 2026 13
- UnitedHealth Group Announces Earnings Release Date - Yahoo Finance ue, 17 Mar 2026 07
- UnitedHealth Group (UNH): One of the Stocks That Can Make You Richer in 2026 - Yahoo Finance hu, 02 Apr 2026 07
- UnitedHealth Stock Is Down 18% in 2026 and Keeps Stumbling. Should You Buy the Dip Monday? - Yahoo Finance Mon, 23 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
447,567.00
+11.81%
|
400,278.00
+7.71%
|
371,622.00
+14.64%
|
324,162.00
|
| Operating Revenue |
|
447,567.00
+11.81%
|
400,278.00
+7.71%
|
371,622.00
+14.64%
|
324,162.00
|
| Cost Of Revenue |
|
364,650.00
+17.30%
|
310,879.00
+10.77%
|
280,664.00
+14.77%
|
244,545.00
|
| Reconciled Cost Of Revenue |
|
364,650.00
+17.30%
|
310,879.00
+10.77%
|
280,664.00
+14.77%
|
244,545.00
|
| Gross Profit |
|
82,917.00
-7.25%
|
89,399.00
-1.71%
|
90,958.00
+14.24%
|
79,617.00
|
| Operating Expense |
|
63,953.00
+11.98%
|
57,112.00
-2.54%
|
58,600.00
+14.49%
|
51,182.00
|
| Other Operating Expenses |
|
59,592.00
+12.41%
|
53,013.00
-2.96%
|
54,628.00
+14.33%
|
47,782.00
|
| Total Expenses |
|
428,603.00
+16.47%
|
367,991.00
+8.47%
|
339,264.00
+14.72%
|
295,727.00
|
| Operating Income |
|
18,964.00
-41.26%
|
32,287.00
-0.22%
|
32,358.00
+13.80%
|
28,435.00
|
| Total Operating Income As Reported |
|
18,964.00
-41.26%
|
32,287.00
-0.22%
|
32,358.00
+13.80%
|
28,435.00
|
| EBITDA |
|
23,060.00
-17.87%
|
28,076.00
-22.72%
|
36,330.00
+14.12%
|
31,835.00
|
| Normalized EBITDA |
|
23,325.00
-35.90%
|
36,386.00
+0.15%
|
36,330.00
+14.12%
|
31,835.00
|
| Reconciled Depreciation |
|
4,361.00
+6.39%
|
4,099.00
+3.20%
|
3,972.00
+16.82%
|
3,400.00
|
| EBIT |
|
18,699.00
-22.01%
|
23,977.00
-25.90%
|
32,358.00
+13.80%
|
28,435.00
|
| Total Unusual Items |
|
-265.00
+96.81%
|
-8,310.00
|
0.00
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
-265.00
+96.81%
|
-8,310.00
|
0.00
|
0.00
|
| Special Income Charges |
|
-265.00
+96.81%
|
-8,310.00
|
0.00
|
0.00
|
| Net Income |
|
12,056.00
-16.31%
|
14,405.00
-35.64%
|
22,381.00
+11.24%
|
20,120.00
|
| Pretax Income |
|
14,697.00
-26.77%
|
20,071.00
-31.06%
|
29,112.00
+10.51%
|
26,343.00
|
| Net Non Operating Interest Income Expense |
|
-4,002.00
-2.46%
|
-3,906.00
-20.33%
|
-3,246.00
-55.16%
|
-2,092.00
|
| Interest Expense Non Operating |
|
4,002.00
+2.46%
|
3,906.00
+20.33%
|
3,246.00
+55.16%
|
2,092.00
|
| Net Interest Income |
|
-4,002.00
-2.46%
|
-3,906.00
-20.33%
|
-3,246.00
-55.16%
|
-2,092.00
|
| Interest Expense |
|
4,002.00
+2.46%
|
3,906.00
+20.33%
|
3,246.00
+55.16%
|
2,092.00
|
| Other Income Expense |
|
-265.00
+96.81%
|
-8,310.00
-303.23%
|
4,089.00
+101.43%
|
2,030.00
|
| Gain On Sale Of Security |
|
—
|
—
|
4,089.00
+101.43%
|
2,030.00
|
| Gain On Sale Of Business |
|
-265.00
+96.81%
|
-8,310.00
|
0.00
|
0.00
|
| Tax Provision |
|
1,890.00
-60.86%
|
4,829.00
-19.09%
|
5,968.00
+4.63%
|
5,704.00
|
| Tax Rate For Calcs |
|
0.00
-46.47%
|
0.00
+17.56%
|
0.00
-5.53%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-34.19
+98.29%
|
-2,002.71
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
12,807.00
-15.98%
|
15,242.00
-34.14%
|
23,144.00
+12.14%
|
20,639.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
12,056.00
-16.31%
|
14,405.00
-35.64%
|
22,381.00
+11.24%
|
20,120.00
|
| Net Income From Continuing And Discontinued Operation |
|
12,056.00
-16.31%
|
14,405.00
-35.64%
|
22,381.00
+11.24%
|
20,120.00
|
| Net Income Continuous Operations |
|
12,807.00
-15.98%
|
15,242.00
-34.14%
|
23,144.00
+12.14%
|
20,639.00
|
| Minority Interests |
|
-751.00
+10.27%
|
-837.00
-9.70%
|
-763.00
-47.01%
|
-519.00
|
| Normalized Income |
|
12,286.82
-40.68%
|
20,712.29
-7.46%
|
22,381.00
+11.24%
|
20,120.00
|
| Net Income Common Stockholders |
|
12,056.00
-16.31%
|
14,405.00
-35.64%
|
22,381.00
+11.24%
|
20,120.00
|
| Diluted EPS |
|
13.23
-14.70%
|
15.51
-35.00%
|
23.86
+12.65%
|
21.18
|
| Basic EPS |
|
13.31
-15.46%
|
15.74
-35.00%
|
24.22
+12.44%
|
21.54
|
| Basic Average Shares |
|
905.84
-1.00%
|
915.00
-0.97%
|
924.00
-1.07%
|
934.00
|
| Diluted Average Shares |
|
911.00
-1.94%
|
929.00
-0.96%
|
938.00
-1.26%
|
950.00
|
| Diluted NI Availto Com Stockholders |
|
12,056.00
-16.31%
|
14,405.00
-35.64%
|
22,381.00
+11.24%
|
20,120.00
|
| Depreciation Amortization Depletion Income Statement |
|
4,361.00
+6.39%
|
4,099.00
+3.20%
|
3,972.00
+16.82%
|
3,400.00
|
| Depreciation And Amortization In Income Statement |
|
4,361.00
+6.39%
|
4,099.00
+3.20%
|
3,972.00
+16.82%
|
3,400.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
309,581.00
+3.79%
|
298,278.00
+8.97%
|
273,720.00
+11.40%
|
245,705.00
|
| Current Assets |
|
90,582.00
+5.60%
|
85,779.00
+9.36%
|
78,437.00
+13.56%
|
69,069.00
|
| Cash Cash Equivalents And Short Term Investments |
|
28,121.00
-3.41%
|
29,113.00
-1.74%
|
29,628.00
+6.15%
|
27,911.00
|
| Cash And Cash Equivalents |
|
24,365.00
-3.74%
|
25,312.00
-0.45%
|
25,427.00
+8.83%
|
23,365.00
|
| Other Short Term Investments |
|
3,756.00
-1.18%
|
3,801.00
-9.52%
|
4,201.00
-7.59%
|
4,546.00
|
| Receivables |
|
52,715.00
+8.79%
|
48,454.00
+24.34%
|
38,970.00
+27.98%
|
30,450.00
|
| Accounts Receivable |
|
23,018.00
+2.92%
|
22,365.00
+5.12%
|
21,276.00
+20.33%
|
17,681.00
|
| Gross Accounts Receivable |
|
24,226.00
+3.75%
|
23,350.00
+4.82%
|
22,276.00
+20.03%
|
18,558.00
|
| Allowance For Doubtful Accounts Receivable |
|
-1,208.00
-22.64%
|
-985.00
+1.50%
|
-1,000.00
-14.03%
|
-877.00
|
| Other Receivables |
|
29,697.00
+13.83%
|
26,089.00
+47.45%
|
17,694.00
+38.57%
|
12,769.00
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
9,746.00
+18.68%
|
8,212.00
-16.54%
|
9,839.00
-8.12%
|
10,708.00
|
| Total Non Current Assets |
|
218,999.00
+3.06%
|
212,499.00
+8.82%
|
195,283.00
+10.56%
|
176,636.00
|
| Net PPE |
|
10,762.00
+1.98%
|
10,553.00
-7.83%
|
11,450.00
+13.05%
|
10,128.00
|
| Gross PPE |
|
18,308.00
+4.47%
|
17,524.00
-5.22%
|
18,489.00
+8.39%
|
17,058.00
|
| Accumulated Depreciation |
|
-7,546.00
-8.25%
|
-6,971.00
+0.97%
|
-7,039.00
-1.57%
|
-6,930.00
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
387.00
+6.32%
|
364.00
-48.88%
|
712.00
+2.15%
|
697.00
|
| Buildings And Improvements |
|
4,087.00
-3.04%
|
4,215.00
-24.37%
|
5,573.00
+0.98%
|
5,519.00
|
| Machinery Furniture Equipment |
|
13,834.00
+6.87%
|
12,945.00
+6.07%
|
12,204.00
+12.56%
|
10,842.00
|
| Goodwill And Other Intangible Assets |
|
130,973.00
+0.75%
|
130,002.00
+9.31%
|
118,926.00
+10.37%
|
107,753.00
|
| Goodwill |
|
110,499.00
+3.53%
|
106,734.00
+2.89%
|
103,732.00
+11.12%
|
93,352.00
|
| Other Intangible Assets |
|
20,474.00
-12.01%
|
23,268.00
+53.14%
|
15,194.00
+5.51%
|
14,401.00
|
| Investments And Advances |
|
54,251.00
+3.62%
|
52,354.00
+9.97%
|
47,609.00
+8.88%
|
43,728.00
|
| Other Non Current Assets |
|
23,013.00
+17.47%
|
19,590.00
+13.25%
|
17,298.00
+15.11%
|
15,027.00
|
| Total Liabilities Net Minority Interest |
|
207,883.00
+6.23%
|
195,687.00
+11.95%
|
174,801.00
+9.69%
|
159,358.00
|
| Current Liabilities |
|
114,897.00
+10.72%
|
103,769.00
+4.76%
|
99,054.00
+11.00%
|
89,237.00
|
| Payables And Accrued Expenses |
|
77,369.00
+12.85%
|
68,561.00
+6.54%
|
64,353.00
+13.36%
|
56,771.00
|
| Payables |
|
77,369.00
+12.85%
|
68,561.00
+6.54%
|
64,353.00
+13.36%
|
56,771.00
|
| Accounts Payable |
|
77,369.00
+12.85%
|
68,561.00
+6.54%
|
64,353.00
+13.36%
|
56,771.00
|
| Current Debt And Capital Lease Obligation |
|
6,069.00
+33.53%
|
4,545.00
+6.34%
|
4,274.00
+37.43%
|
3,110.00
|
| Current Debt |
|
6,069.00
+33.53%
|
4,545.00
+6.34%
|
4,274.00
+37.43%
|
3,110.00
|
| Current Deferred Liabilities |
|
3,413.00
+2.89%
|
3,317.00
-1.13%
|
3,355.00
+9.11%
|
3,075.00
|
| Current Deferred Revenue |
|
3,413.00
+2.89%
|
3,317.00
-1.13%
|
3,355.00
+9.11%
|
3,075.00
|
| Other Current Liabilities |
|
28,046.00
+2.56%
|
27,346.00
+1.01%
|
27,072.00
+3.01%
|
26,281.00
|
| Total Non Current Liabilities Net Minority Interest |
|
92,986.00
+1.16%
|
91,918.00
+21.35%
|
75,747.00
+8.02%
|
70,121.00
|
| Long Term Debt And Capital Lease Obligation |
|
72,320.00
-0.05%
|
72,359.00
+24.19%
|
58,263.00
+6.88%
|
54,513.00
|
| Long Term Debt |
|
72,320.00
-0.05%
|
72,359.00
+24.19%
|
58,263.00
+6.88%
|
54,513.00
|
| Non Current Deferred Liabilities |
|
2,421.00
-33.12%
|
3,620.00
+19.83%
|
3,021.00
+9.10%
|
2,769.00
|
| Non Current Deferred Taxes Liabilities |
|
2,421.00
-33.12%
|
3,620.00
+19.83%
|
3,021.00
+9.10%
|
2,769.00
|
| Other Non Current Liabilities |
|
18,245.00
+14.47%
|
15,939.00
+10.21%
|
14,463.00
+12.65%
|
12,839.00
|
| Stockholders Equity |
|
94,110.00
+1.57%
|
92,658.00
+4.40%
|
88,756.00
+14.12%
|
77,772.00
|
| Common Stock Equity |
|
94,110.00
+1.57%
|
92,658.00
+4.40%
|
88,756.00
+14.12%
|
77,772.00
|
| Capital Stock |
|
9.00
+0.00%
|
9.00
+0.00%
|
9.00
+0.00%
|
9.00
|
| Common Stock |
|
9.00
+0.00%
|
9.00
+0.00%
|
9.00
+0.00%
|
9.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
905.84
-1.00%
|
915.00
-0.97%
|
924.00
-1.07%
|
934.00
|
| Ordinary Shares Number |
|
905.84
-1.00%
|
915.00
-0.97%
|
924.00
-1.07%
|
934.00
|
| Additional Paid In Capital |
|
559.00
|
0.00
|
—
|
—
|
| Retained Earnings |
|
95,603.00
-0.45%
|
96,036.00
+0.27%
|
95,774.00
+11.16%
|
86,156.00
|
| Gains Losses Not Affecting Retained Earnings |
|
-2,061.00
+39.15%
|
-3,387.00
+51.80%
|
-7,027.00
+16.28%
|
-8,393.00
|
| Minority Interest |
|
7,588.00
-23.61%
|
9,933.00
-2.26%
|
10,163.00
+18.52%
|
8,575.00
|
| Other Equity Adjustments |
|
-2,061.00
+39.15%
|
-3,387.00
+51.80%
|
-7,027.00
+16.28%
|
-8,393.00
|
| Total Equity Gross Minority Interest |
|
101,698.00
-0.87%
|
102,591.00
+3.71%
|
98,919.00
+14.56%
|
86,347.00
|
| Total Capitalization |
|
166,430.00
+0.86%
|
165,017.00
+12.24%
|
147,019.00
+11.14%
|
132,285.00
|
| Working Capital |
|
-24,315.00
-35.16%
|
-17,990.00
+12.74%
|
-20,617.00
-2.23%
|
-20,168.00
|
| Invested Capital |
|
172,499.00
+1.73%
|
169,562.00
+12.08%
|
151,293.00
+11.74%
|
135,395.00
|
| Total Debt |
|
78,389.00
+1.93%
|
76,904.00
+22.97%
|
62,537.00
+8.53%
|
57,623.00
|
| Net Debt |
|
54,024.00
+4.71%
|
51,592.00
+39.02%
|
37,110.00
+8.33%
|
34,258.00
|
| Net Tangible Assets |
|
-36,863.00
+1.29%
|
-37,344.00
-23.78%
|
-30,170.00
-0.63%
|
-29,981.00
|
| Tangible Book Value |
|
-36,863.00
+1.29%
|
-37,344.00
-23.78%
|
-30,170.00
-0.63%
|
-29,981.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
19,697.00
-18.62%
|
24,204.00
-16.73%
|
29,068.00
+10.92%
|
26,206.00
|
| Cash Flow From Continuing Operating Activities |
|
19,697.00
-18.62%
|
24,204.00
-16.73%
|
29,068.00
+10.92%
|
26,206.00
|
| Net Income From Continuing Operations |
|
12,807.00
-15.98%
|
15,242.00
-34.14%
|
23,144.00
+12.14%
|
20,639.00
|
| Depreciation Amortization Depletion |
|
4,361.00
+6.39%
|
4,099.00
+3.20%
|
3,972.00
+16.82%
|
3,400.00
|
| Depreciation And Amortization |
|
4,361.00
+6.39%
|
4,099.00
+3.20%
|
3,972.00
+16.82%
|
3,400.00
|
| Other Non Cash Items |
|
763.00
+122.70%
|
-3,361.00
-565.54%
|
-505.00
-52.57%
|
-331.00
|
| Stock Based Compensation |
|
971.00
-4.62%
|
1,018.00
-3.87%
|
1,059.00
+14.49%
|
925.00
|
| Deferred Tax |
|
-1,752.00
-491.89%
|
-296.00
-20.82%
|
-245.00
+63.60%
|
-673.00
|
| Deferred Income Tax |
|
-1,752.00
-491.89%
|
-296.00
-20.82%
|
-245.00
+63.60%
|
-673.00
|
| Operating Gains Losses |
|
265.00
-96.81%
|
8,310.00
|
—
|
—
|
| Change In Working Capital |
|
2,282.00
+382.43%
|
-808.00
-149.18%
|
1,643.00
-26.85%
|
2,246.00
|
| Change In Receivables |
|
-764.00
+46.83%
|
-1,437.00
+53.85%
|
-3,114.00
-23.42%
|
-2,523.00
|
| Changes In Account Receivables |
|
-764.00
+46.83%
|
-1,437.00
+53.85%
|
-3,114.00
-23.42%
|
-2,523.00
|
| Change In Payables And Accrued Expense |
|
7,489.00
+50.81%
|
4,966.00
-29.04%
|
6,998.00
+16.30%
|
6,017.00
|
| Change In Payable |
|
7,489.00
+50.81%
|
4,966.00
-29.04%
|
6,998.00
+16.30%
|
6,017.00
|
| Change In Account Payable |
|
1,665.00
-32.40%
|
2,463.00
-29.95%
|
3,516.00
+79.02%
|
1,964.00
|
| Change In Other Working Capital |
|
163.00
+182.74%
|
-197.00
-197.04%
|
203.00
+61.11%
|
126.00
|
| Change In Other Current Assets |
|
-4,606.00
-11.26%
|
-4,140.00
-69.39%
|
-2,444.00
-77.87%
|
-1,374.00
|
| Change In Other Current Liabilities |
|
—
|
—
|
—
|
-1,374.00
|
| Investing Cash Flow |
|
-8,685.00
+57.69%
|
-20,527.00
-31.80%
|
-15,574.00
+45.31%
|
-28,476.00
|
| Cash Flow From Continuing Investing Activities |
|
-8,685.00
+57.69%
|
-20,527.00
-31.80%
|
-15,574.00
+45.31%
|
-28,476.00
|
| Net PPE Purchase And Sale |
|
-3,622.00
-3.52%
|
-3,499.00
-3.34%
|
-3,386.00
-20.84%
|
-2,802.00
|
| Purchase Of PPE |
|
-3,622.00
-3.52%
|
-3,499.00
-3.34%
|
-3,386.00
-20.84%
|
-2,802.00
|
| Capital Expenditure |
|
-3,622.00
-3.52%
|
-3,499.00
-3.34%
|
-3,386.00
-20.84%
|
-2,802.00
|
| Net Investment Purchase And Sale |
|
361.00
-31.24%
|
525.00
+129.54%
|
-1,777.00
+74.01%
|
-6,837.00
|
| Purchase Of Investment |
|
-17,373.00
+36.38%
|
-27,308.00
-49.11%
|
-18,314.00
+2.71%
|
-18,825.00
|
| Sale Of Investment |
|
17,734.00
-36.28%
|
27,833.00
+68.31%
|
16,537.00
+37.95%
|
11,988.00
|
| Net Business Purchase And Sale |
|
-4,509.00
+66.37%
|
-13,408.00
-32.28%
|
-10,136.00
+52.76%
|
-21,458.00
|
| Purchase Of Business |
|
-4,509.00
+66.37%
|
-13,408.00
-32.28%
|
-10,136.00
+52.76%
|
-21,458.00
|
| Gain Loss On Sale Of Business |
|
265.00
-96.81%
|
8,310.00
|
0.00
|
0.00
|
| Net Other Investing Changes |
|
-915.00
+77.93%
|
-4,145.00
-1407.27%
|
-275.00
-110.49%
|
2,621.00
|
| Financing Cash Flow |
|
-11,644.00
-231.55%
|
-3,512.00
+69.54%
|
-11,529.00
-372.81%
|
4,226.00
|
| Cash Flow From Continuing Financing Activities |
|
-11,644.00
-231.55%
|
-3,512.00
+69.54%
|
-11,529.00
-372.81%
|
4,226.00
|
| Net Issuance Payments Of Debt |
|
726.00
-95.05%
|
14,660.00
+242.52%
|
4,280.00
-65.86%
|
12,536.00
|
| Issuance Of Debt |
|
2,969.00
-83.33%
|
17,811.00
+178.56%
|
6,394.00
-56.85%
|
14,819.00
|
| Repayment Of Debt |
|
-3,050.00
-1.67%
|
-3,000.00
-41.18%
|
-2,125.00
+29.52%
|
-3,015.00
|
| Long Term Debt Issuance |
|
2,969.00
-83.33%
|
17,811.00
+178.56%
|
6,394.00
-56.85%
|
14,819.00
|
| Long Term Debt Payments |
|
-3,050.00
-1.67%
|
-3,000.00
-41.18%
|
-2,125.00
+29.52%
|
-3,015.00
|
| Net Long Term Debt Issuance |
|
-81.00
-100.55%
|
14,811.00
+246.94%
|
4,269.00
-63.83%
|
11,804.00
|
| Net Short Term Debt Issuance |
|
807.00
+634.44%
|
-151.00
-1472.73%
|
11.00
-98.50%
|
732.00
|
| Net Common Stock Issuance |
|
-4,718.00
+34.05%
|
-7,154.00
-7.63%
|
-6,647.00
-15.66%
|
-5,747.00
|
| Common Stock Payments |
|
-5,545.00
+38.39%
|
-9,000.00
-12.50%
|
-8,000.00
-14.29%
|
-7,000.00
|
| Common Stock Dividend Paid |
|
-7,916.00
-5.08%
|
-7,533.00
-11.42%
|
-6,761.00
-12.85%
|
-5,991.00
|
| Cash Dividends Paid |
|
-7,916.00
-5.08%
|
-7,533.00
-11.42%
|
-6,761.00
-12.85%
|
-5,991.00
|
| Repurchase Of Capital Stock |
|
-5,545.00
+38.39%
|
-9,000.00
-12.50%
|
-8,000.00
-14.29%
|
-7,000.00
|
| Net Other Financing Charges |
|
264.00
+107.58%
|
-3,485.00
-45.15%
|
-2,401.00
-170.04%
|
3,428.00
|
| Changes In Cash |
|
-632.00
-483.03%
|
165.00
-91.60%
|
1,965.00
+0.46%
|
1,956.00
|
| Effect Of Exchange Rate Changes |
|
40.00
+165.57%
|
-61.00
-162.89%
|
97.00
+185.29%
|
34.00
|
| Beginning Cash Position |
|
25,312.00
-0.45%
|
25,427.00
+8.83%
|
23,365.00
+9.31%
|
21,375.00
|
| End Cash Position |
|
24,365.00
-3.74%
|
25,312.00
-0.45%
|
25,427.00
+8.83%
|
23,365.00
|
| Free Cash Flow |
|
16,075.00
-22.36%
|
20,705.00
-19.38%
|
25,682.00
+9.73%
|
23,404.00
|
| Interest Paid Supplemental Data |
|
4,030.00
+12.13%
|
3,594.00
+18.42%
|
3,035.00
+56.04%
|
1,945.00
|
| Income Tax Paid Supplemental Data |
|
3,714.00
-19.61%
|
4,620.00
-23.99%
|
6,078.00
+16.39%
|
5,222.00
|
| Common Stock Issuance |
|
827.00
-55.20%
|
1,846.00
+36.44%
|
1,353.00
+7.98%
|
1,253.00
|
| Issuance Of Capital Stock |
|
827.00
-55.20%
|
1,846.00
+36.44%
|
1,353.00
+7.98%
|
1,253.00
|
| Other Cash Adjustment Outside Changein Cash |
|
-355.00
-62.10%
|
-219.00
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-06 View
- 42026-04-06 View
- 42026-04-06 View
- 42026-04-06 View
- 42026-04-06 View
- 42026-04-06 View
- 42026-04-06 View
- 42026-04-06 View
- 42026-04-06 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|